These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 32448605)
1. Molecular determinants of the interaction between glioblastoma CD133 Shevchenko V; Arnotskaya N; Pak O; Sharma A; Sharma HS; Khotimchenko Y; Bryukhovetskiy A; Bryukhovetskiy I Int Rev Neurobiol; 2020; 151():155-169. PubMed ID: 32448605 [TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β mimics the key proteome properties of CD133 Bryukhovetskiy I; Shevchenko V; Arnotskaya N; Kushnir T; Pak O; Victor Z; Zaitsev S; Khotimchenko Y; Bryukhovetskiy A; Sharma A; Sharma HS Int Rev Neurobiol; 2020; 151():219-242. PubMed ID: 32448609 [TBL] [Abstract][Full Text] [Related]
3. Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma. Shevchenko V; Arnotskaya N; Zaitsev S; Sharma A; Sharma HS; Bryukhovetskiy A; Pak O; Khotimchenko Y; Bryukhovetskiy I Int Rev Neurobiol; 2020; 151():185-200. PubMed ID: 32448607 [TBL] [Abstract][Full Text] [Related]
4. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma. Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699 [TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways. Hallal S; Mallawaaratchy DM; Wei H; Ebrahimkhani S; Stringer BW; Day BW; Boyd AW; Guillemin GJ; Buckland ME; Kaufman KL Mol Neurobiol; 2019 Jun; 56(6):4566-4581. PubMed ID: 30353492 [TBL] [Abstract][Full Text] [Related]
6. Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells. Smiley SB; Yun Y; Ayyagari P; Shannon HE; Pollok KE; Vannier MW; Das SK; Veronesi MC Pharm Res; 2021 Jun; 38(6):1067-1079. PubMed ID: 34100216 [TBL] [Abstract][Full Text] [Related]
7. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866 [TBL] [Abstract][Full Text] [Related]
8. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression. Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848 [TBL] [Abstract][Full Text] [Related]
9. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid. Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261 [TBL] [Abstract][Full Text] [Related]
10. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372 [TBL] [Abstract][Full Text] [Related]
11. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity. Brown DV; Filiz G; Daniel PM; Hollande F; Dworkin S; Amiridis S; Kountouri N; Ng W; Morokoff AP; Mantamadiotis T PLoS One; 2017; 12(2):e0172791. PubMed ID: 28241049 [TBL] [Abstract][Full Text] [Related]
12. Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy. Daniele S; Zappelli E; Natali L; Martini C; Trincavelli ML Cell Death Dis; 2014 Nov; 5(11):e1539. PubMed ID: 25429616 [TBL] [Abstract][Full Text] [Related]
13. Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype. Liu YC; Lee IC; Chen PY J Neurooncol; 2018 May; 137(3):511-522. PubMed ID: 29357090 [TBL] [Abstract][Full Text] [Related]
14. Brain tumor stem cells from an adenoid glioblastoma multiforme. Oka N; Soeda A; Noda S; Iwama T Neurol Med Chir (Tokyo); 2009 Apr; 49(4):146-50; discussion 150-1. PubMed ID: 19398857 [TBL] [Abstract][Full Text] [Related]
15. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells. Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870 [TBL] [Abstract][Full Text] [Related]
16. Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells. Volovetz J; Berezovsky AD; Alban T; Chen Y; Lauko A; Aranjuez GF; Burtscher A; Shibuya K; Silver DJ; Peterson J; Manor D; McDonald JA; Lathia JD Cell Death Dis; 2020 Feb; 11(2):152. PubMed ID: 32102991 [TBL] [Abstract][Full Text] [Related]
17. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review). Bryukhovetskiy I; Ponomarenko A; Lyakhova I; Zaitsev S; Zayats Y; Korneyko M; Eliseikina M; Mischenko P; Shevchenko V; Shanker Sharma H; Sharma A; Khotimchenko Y Int J Mol Med; 2018 Aug; 42(2):691-702. PubMed ID: 29749540 [TBL] [Abstract][Full Text] [Related]
18. Glutamine deprivation in glioblastoma stem cells triggers autophagic SIRT3 degradation to epigenetically restrict CD133 expression and stemness. Xing Z; Jiang X; Chen Y; Wang T; Li X; Wei X; Fan Q; Yang J; Wu H; Cheng J; Cai R Apoptosis; 2024 Oct; 29(9-10):1619-1631. PubMed ID: 39068621 [TBL] [Abstract][Full Text] [Related]
19. Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57. Zhu X; Prasad S; Gaedicke S; Hettich M; Firat E; Niedermann G Oncotarget; 2015 Jan; 6(1):171-84. PubMed ID: 25426558 [TBL] [Abstract][Full Text] [Related]
20. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes. Jin F; Zhao L; Zhao HY; Guo SG; Feng J; Jiang XB; Zhang SL; Wei YJ; Fu R; Zhao JS Neuroscience; 2008 Jun; 154(2):541-50. PubMed ID: 18462887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]